Trade Varex Imaging - VREX CFD

Trading Conditions
Spread0.07
Long position overnight fee
Long position overnight fee

Margin. Your investment
$1,000.00
Overnight fee
Charges from full value of position
-0.026179 %
(-$1.05)

Trade size with leverage ~ $5,000.00

Short position overnight fee ~ $4,000.00


-0.026179%
Short position overnight fee
Short position overnight fee

Margin. Your investment
$1,000.00
Overnight fee
Charges from full value of position
0.003957 %
($0.16)

Trade size with leverage ~ $5,000.00

Short position overnight fee ~ $4,000.00


0.003957%
Overnight fee time21:00 (UTC)
CurrencyUSD
Min traded quantity1
Margin20
Stock exchangeUnited States of America
Commission on trade10%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close16.89
Open16.7
1-Year Change-5.65%
Day's Range16 - 16.7

Varex Imaging Company profile

About Varex Imaging Corp

Varex Imaging Corporation is a designer and manufacturer of X-ray tubes, digital detectors, linear accelerators and other image software processing solutions. The Company’s segments include Medical and Industrial. The X-ray imaging system manufacturers use the Company’s components for medical imaging, cargo screening and border security, to detect, diagnose and protect. The Medical business segment designs, manufactures, sells and services X-ray imaging components for use in a range of applications, including radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, radiation therapy and computer-aided detection. The Industrial business segment designs, manufactures, sells and services products for use in security and industrial inspection applications, such as cargo screening at ports and borders and non-destructive examination in a range of applications.

Financial summary

BRIEF: For the 13 weeks ended 31 December 2021, Varex Imaging Corp revenues increased 12% to $198.8M. Net income totaled $1.4M vs. loss of $6.4M. Revenues reflect Medical segment increase of 12% to $155.7M, Industrial segment increase of 14% to $43.1M, APAC segment increase of 25% to $70.9M, EMEA segment increase of 16% to $67.4M. Net Income reflects Selling, General & Administrative decrease of 8% to $29.1M (expense).